国产大片久久久久久-亚洲国产婷婷久久-久久精品国产不卡-久久不卡精品国产-国产乱码一区二区

產(chǎn)品展示 / products 您的位置:網(wǎng)站首頁 > 產(chǎn)品展示 > 細(xì)胞庫 > 細(xì)胞系 > 人膀胱癌細(xì)胞SW1710
相關(guān)文章

Related articles

人膀胱癌細(xì)胞SW1710

人膀胱癌細(xì)胞SW1710

簡要描述:青旗(上海)生物技術(shù)發(fā)展有限公司,總部位于上海浦東新區(qū),依托本地高校資源,逐步發(fā)展成為以生物技術(shù)為主的研發(fā)、生產(chǎn)、培訓(xùn)為一體的綜合化產(chǎn)業(yè)平臺,在標(biāo)準(zhǔn)化細(xì)胞庫建立及細(xì)胞藥物前端模型方面成果顯著。公司生產(chǎn)經(jīng)營原代細(xì)胞、細(xì)胞系、ELISA試劑盒、感受態(tài)細(xì)胞和HPLC檢測等科研產(chǎn)品與服務(wù)。我們秉承對用戶負(fù)責(zé)的態(tài)度,以對科研的高度嚴(yán)謹(jǐn),以嚴(yán)格的質(zhì)量控制,為廣大生物醫(yī)學(xué)科研用戶提供更優(yōu)質(zhì)的服務(wù)!

更新時間:2021-05-25

廠商性質(zhì):生產(chǎn)廠家

瀏覽次數(shù):327

詳情介紹
品牌其他品牌貨號BFN60811444
規(guī)格T25培養(yǎng)瓶x1 1.5ml凍存管x2供貨周期現(xiàn)貨
主要用途僅供科研應(yīng)用領(lǐng)域醫(yī)療衛(wèi)生,生物產(chǎn)業(yè)

細(xì)胞名稱

人膀胱癌細(xì)SW1710

img1

貨物編碼

BFN60811444

產(chǎn)品規(guī)格

T25培養(yǎng)x1

1.5ml凍存x2

細(xì)胞數(shù)量

1x10^6

1x10^6

保存溫度

37

-198

運(yùn)輸方式

常溫保溫運(yùn)輸

干冰運(yùn)輸

安全等級

1

用途限制

僅供科   3

 

培養(yǎng)體系

DMEM(HYCLONE SH30022.01)+10%FBS+1%三抗

培養(yǎng)溫度

37

二氧化碳濃度

5%

簡介

人膀胱癌細(xì)SW171084歲女性供體

注釋

Part of: BLA-40 bladder carcinoma cell line panel.

Part of: Cancer Cell Line Encyclopedia (CCLE) project.

Part of: COSMIC cell lines project.

Part of: UBC-40 urothelial bladder cancer cell line index.

From: Scott and White Clinic; Temple; USA.

Doubling time: ~25-32 hours (DSMZ).

Microsatellite instability: Stable (MSS) (Sanger).

Omics: CNV analysis.

Omics: Deep exome analysis.

Omics: Deep RNAseq analysis.

Omics: DNA methylation analysis.

Omics: SNP array analysis.

Omics: Transcriptome analysis.

基因突變

TERT c.228C>T (-124C>T); in promoter (PubMed=24035680).

HLA信息

 

STR信息

Amelogenin X

CSF1PO 11,12

D5S818 12

D7S820 8,11

D13S317 12

D16S539 8,11

TH01 7,10 (Cosmic-CLP)

 7,8,9.3 (DSMZ)

 7,9.3 (PubMed=27270441)

TPOX 9,11

vWA 16,17

 

參考文獻(xiàn)

PubMed=27270441; DOI=10.1038/onc.2016.172

 Nickerson M.L., Witte N., Im K.M., Turan S., Owens C., Misner K., Tsang S.X., Cai Z., Wu S., Dean M., Costello J.C., Theodorescu D.

 Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.

 Oncogene 36:35-46(2017)

 

PubMed=29732388; DOI=10.3233/BLC-180167

 Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.

 Systematic review: characteristics and preclinical uses of bladder cancer cell lines.

 Bladder Cancer 4:169-183(2018)

 

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747

 Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.

 An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

 Cancer Res. 79:1263-1273(2019)

 

PubMed=31068700; DOI=10.1038/s41586-019-1186-3

 Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.

 Next-generation characterization of the Cancer Cell Line Encyclopedia.

 Nature 569:503-508(2019)



留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗證碼:

    請輸入計算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7

聯(lián)